| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/18/2001 | CA2379362A1 Respiratory syncytial viruses expressing immune modulatory molecules |
| 01/18/2001 | CA2379199A1 Oxathiepino[6,5-b]dihydropyridines, and related compositions and methods |
| 01/18/2001 | CA2379133A1 Human proteins involved in detoxification |
| 01/18/2001 | CA2378763A1 Tuberculosis vaccine and diagnostics based on the mycobacterium tuberculosis esat-6 gene family |
| 01/18/2001 | CA2378595A1 Benzoylpyridazines |
| 01/18/2001 | CA2378567A1 Novel myxoma genes for immune modulation |
| 01/18/2001 | CA2378552A1 Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines |
| 01/18/2001 | CA2378179A1 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 01/18/2001 | CA2377502A1 Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents |
| 01/18/2001 | CA2340757A1 Delivery of liposomal-encapsulated antioxidants and applications thereof |
| 01/17/2001 | EP1069124A1 2-Benzimidazolylamine compounds as ORL1-receptor agonists |
| 01/17/2001 | EP1069114A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 01/17/2001 | EP1068524A1 Corticotropin releasing factor receptor 1-deficient mice |
| 01/17/2001 | EP1068221A2 Template associated npy y2-receptor agonists |
| 01/17/2001 | EP1068194A1 Pde iv inhibiting pyridine derivatives |
| 01/17/2001 | EP1068180A1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloprotenase inhibitors |
| 01/17/2001 | EP1067953A1 Methods for treating an ischemic disorder and improving stroke outcome |
| 01/17/2001 | EP1067940A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 01/17/2001 | EP1067838A1 Treatment of respiratory disease and otitis media |
| 01/17/2001 | CN1280619A (Chlamydia trachomatic) genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 01/17/2001 | CN1280579A Novel polymorphic forms of cipamfylline |
| 01/17/2001 | CN1280463A Smoking products containing antioxidants |
| 01/17/2001 | CN1279992A Medicine for curing and preventing upper respiratory infection and its preparing method |
| 01/17/2001 | CN1279985A Compound toad preparation for curing asthma |
| 01/17/2001 | CN1279978A Ginkgo and gastrodia taber capsule |
| 01/17/2001 | CN1279972A Chinese medicine eliminating thick sputum and clearing away heat and toxic material and its preparing method |
| 01/17/2001 | CN1279942A Medicinal aerosol for curing respiratory system disease |
| 01/17/2001 | CN1060674C Chinese herb medicine composition for curing rhinitis and its preparing method |
| 01/17/2001 | CN1060662C Foot-washing autitussive powder |
| 01/17/2001 | CN1060660C Chinese herb medicine powder for rhinitis |
| 01/17/2001 | CN1060652C Rhinitis liniment and its preparation |
| 01/16/2001 | US6175021 Human non-pancreatic secretory phospholipase a2 (spla2); inhibits release of arachidonic acid to treat septic shock; ((3-(2-amino-1,2-dioxoethyl)-2-methyl-1-(phenylmethyl)-1h-indol-4 -yl)oxylacetic acid, for example |
| 01/16/2001 | US6175013 1-(2-methoxybenzyl)-2-((4-phenyl-1-piperazinyl)methyl)-4-(1h -indol-3-ylmethyl)-2-imidazoline, for example; adminstering to treat anxiety, depression, psychosis, and schizophrenia |
| 01/16/2001 | US6174994 7TM receptor (H2CAA71) |
| 01/16/2001 | US6174993 Short peptides which selectively modulate the activity of serine/threonine kinases |
| 01/16/2001 | US6174896 Quinuclidine derivatives and medicinal composition thereof |
| 01/16/2001 | US6174895 1-aryl-3-arylmethyl-1,8-naphthyridin-4(1H)-ones |
| 01/16/2001 | US6174887 Amide compounds and use of the same |
| 01/16/2001 | US6174872 Immunotherapy of allergic asthma in both its early and late stages by administering to the mucosa a polynucleotide encoding an asthma-initiating antigen and immunostimulatory neucleotide seqence stimulating the th1 lymhocytes |
| 01/16/2001 | US6174714 Lyss |
| 01/16/2001 | US6174676 Cytokine-stress- and oncoprotein-activated human protein kinase kinases |
| 01/16/2001 | CA2314008A1 2-benzimidazolylamine compounds as orl1-receptor agonists |
| 01/11/2001 | WO2001002571A2 An interleukin-1 receptor antagonist and uses thereof |
| 01/11/2001 | WO2001002569A2 Human immune response molecules |
| 01/11/2001 | WO2001002406A1 Potassium channel blocking agents |
| 01/11/2001 | WO2001002403A1 METHOD FOR PREPARING SUBSTITUTED [1,4]DIAZEPINO[6,7,1-hi]INDOL-4-ONES |
| 01/11/2001 | WO2001002388A1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 01/11/2001 | WO2001002387A1 N-imidazolylmethyl carboxamides as nitric oxide production inhibitors |
| 01/11/2001 | WO2001002381A1 Piperazine derivatives as modulators of chemokine receptor activity |
| 01/11/2001 | WO2001002372A1 Cyclized amino acid derivatives |
| 01/11/2001 | WO2001002024A1 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
| 01/11/2001 | WO2001001995A2 Method for treatment of asthma syndrome |
| 01/11/2001 | WO2001001988A1 Compounds having cytokine inhibitory activity |
| 01/11/2001 | WO2001001973A2 Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 01/11/2001 | WO2001001971A1 Use of cortisol antagonists in the treatment for heat failure |
| 01/11/2001 | WO2001001970A2 New uses potassium channel openers, such as the treatment of epilepsy |
| 01/11/2001 | WO2001001963A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 01/11/2001 | WO2001001962A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 01/11/2001 | WO2000066739A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/11/2001 | WO2000062801A3 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv) |
| 01/11/2001 | WO2000061608A3 Low-molecular inhibitors of complement proteases |
| 01/11/2001 | WO2000059904A3 Compounds and methods to treat cardiac failure and other disorders |
| 01/11/2001 | WO2000058466A3 Protease resistant flint analogs |
| 01/11/2001 | WO2000054770A8 Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis |
| 01/11/2001 | WO2000053596A3 Imidazole compounds as histamine h3 ligands |
| 01/11/2001 | DE19932315A1 Benzoylpyridazine Benzoylpyridazine |
| 01/11/2001 | CA2643231A1 Norepinephrine reuptake inhibitors and methods of using the same |
| 01/11/2001 | CA2378116A1 Human immune response molecules |
| 01/11/2001 | CA2376707A1 Process for the preparation of substituted ¬1,4|diazepino¬6,7,1-hi|indol-4-ones |
| 01/11/2001 | CA2376657A1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 01/11/2001 | CA2376513A1 An interleukin-1 receptor antagonist and uses thereof |
| 01/11/2001 | CA2375751A1 Use of cortisol antagonists in the treatment for heat failure |
| 01/11/2001 | CA2375748A1 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
| 01/11/2001 | CA2375157A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 01/11/2001 | CA2373882A1 Compounds having cytokine inhibitory activity |
| 01/10/2001 | EP1067136A1 New peptide derivatives |
| 01/10/2001 | EP1066828A1 Medicaments |
| 01/10/2001 | EP1066316A1 Cinnamic acid derivatives having cell adhesion modulating activity |
| 01/10/2001 | EP1066290A1 PYRROLO[1,2-a]PYRAZINE sPLA 2 INHIBITOR |
| 01/10/2001 | EP1066286A1 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors |
| 01/10/2001 | EP1066268A1 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonists |
| 01/10/2001 | EP1066265A1 Pyridazinone hydrochloride compound and method for producing the same |
| 01/10/2001 | EP1066261A1 Pyridine derivative and pharmaceutical containing the same |
| 01/10/2001 | EP1066043A2 Materials and methods relating to the treatment of conditions involving mast cells, basophils and eosinophils |
| 01/10/2001 | EP0896525A4 Methods of dry powder inhalation |
| 01/10/2001 | CN1279682A bicyclic kinase inhibitors |
| 01/10/2001 | CN1279681A Piperidylaminomethyltrifluoromethyl cyclic ether compound as p substance antagonist |
| 01/10/2001 | CN1279676A Pseudopolymorphic forms of z-[2-[4-(bis(4-fluorophenyl)methyl]-1-piperazinyl]ethozy] acetic and dihydrochloride |
| 01/10/2001 | CN1279670A Substituted oximes as neurokinin antagonists |
| 01/10/2001 | CN1279612A Modulation of immune responses |
| 01/10/2001 | CN1279236A Salt as thrombin inhibitor |
| 01/10/2001 | CN1279106A Detoxicating, Stasis-dispersing, inflammation-relieving, antalgic and refreshing medicine and its preparing process |
| 01/10/2001 | CN1060465C Antianaphylaxis, anti-asthma and anti-inflammatory new medicine |
| 01/10/2001 | CN1060377C Method for preparing traditional Chinese patent medicine for curing asthma |
| 01/10/2001 | CN1060368C Traditional Chinese medicine for treating cough |
| 01/10/2001 | CN1060354C Medicine for curing rhinitis |
| 01/10/2001 | CN1060353C Medicine for cough and asthma |
| 01/10/2001 | CN1060338C Antitussive liquid and preparation method |
| 01/09/2001 | US6172227 Respiratory system disorders |
| 01/09/2001 | US6172118 Administering 3-phenylcyclobutan-1-one derivatives to treat asthma and respiratory system disorders; phosphodiesterase inhibitors |